HOME >> MEDICINE >> NEWS
Widely used anti-bacterial inhibits parasites that cause malaria and toxoplasmosis

Triclosan, a common antiseptic used in household products such as toothpaste, skin creams, and deodorants, kills the parasites responsible for malaria and toxoplasmosis, even at very low concentrations, reports a team of researchers from the United States and the United Kingdom in the February issue of the International Journal for Parasitology.

Triclosan has been used as an antiseptic since the 1960s. It blocks an enzyme, known as "FabI," that bacteria need to manufacture the fatty acids used in cell membranes. Because animals possess a very different set of enzymes, triclosan does not interfere with this process in humans. This has led to its widespread use in over-the-counter preparations used on the skin or in the mouth.

This common, inexpensive antimicrobial is remarkably effective against these parasites at concentrations that have no detectable toxicity, said first author Rima McLeod, M.D., the Jules and Doris Stein Research to Prevent Blindness Professor of Ophthalmology and Visual Sciences at the University of Chicago.

"That's good news because we urgently need new and better medicines to treat malaria and toxoplasmosis," she added. "The parasites that cause malaria are resistant to many of the available drugs, and there is no medication that affects the latent life-cycle stages of the parasite that causes toxoplasmosis."

"This finding gives us a blueprint to design an effective and safe new drug," said Craig Roberts of the University of Strathclyde, UK.

Malaria affects more than 300 million people worldwide and kills an estimated 3,000 people, mostly children, each day. Although most cases originate in the tropics, there has been a steady increase in U.S. and European repo
'"/>

Contact: John Easton
jeaston@uchospitals.edu
773-702-6241
University of Chicago Medical Center
5-Feb-2001


Page: 1 2 3

Related medicine news :

1. Widely used breast cancer drug not linked to stroke
2. Widely used treatment for head injuries found to be harmful
3. Widely used anti-nausea drug may interfere with cancer chemotherapy
4. Newest Depression Medications Widely Prescribed For Children
5. Widely Used Therapy May Not Be Effective In Treatment Of Acute Stroke
6. Personality, Thought To Be Stable Over Time, Changes In Healthy People Who Take A Widely Used Anti-Depressant
7. Stat5 protein inhibits spread of breast cancer cells
8. Scripps Research Institute group designs DNA vaccine that inhibits growth of cancerous tumors
9. Signal identified that enables malarial parasites to target blood cells
10. A little blue and purple helps body fend off deadly parasites
11. Exercise-induced shortness of breath not always caused by asthma

Post Your Comments:
(Date:6/20/2013)... Dr. Ramtin Kassir is one of ... and NYC and a top cosmetic surgeon in ... is to provide individualized care for a broad spectrum of ... surgeon is partnering with the new and emerging business consultancy ... its specialized needs. , "We are partnering with Tom and ...
(Date:6/20/2013)... June 20, 2013 Volume based manufacturing ... dramatically reduce the retail pricing of both it's WHEY ... replacement products. , Premier Natural Health’s whey protein ... food sources and are formulated to help maintain healthy ... intake and slow the aging process. , Ideal ...
(Date:6/20/2013)... Sydney, Australia (PRWEB) June 20, 2013 ... , research was presented recently, that can show similarities ... food. This could explain the current global obesity ... be addicted to food just as one can be ... Neuroscience and Applied Cognitive Science at the University of ...
(Date:6/19/2013)... (PRWEB) June 20, 2013 With the ... has put together their winter season Santiago day ... adventure day trips in and around Santiago this season, ... into Chile's Central Andes for backcountry skiing, challenging rock ... those who have always dreamed of skiing in ...
(Date:6/19/2013)... York, NY (PRWEB) June 19, 2013 The ... American bands in the country and folk music genre. This ... Brown (who is the lead vocals and guitarist), Jimmy De ... Hopkins (the bass guitarist and in vocals), Coy Bowles (guitarist ... de los Reyes (percussionist). The band was formed in ...
Breaking Medicine News(10 mins):Health News:Celebrity Plastic Surgeon Dr. Kassir Teams Up With X Factor Selling Systems to Enhance Patient Experience 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 3Health News:Research Suggests That Unhealthy Food Addiction Could Explain Global Obesity Epidemic 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 3Health News:Zac Brown Band Tickets for Raleigh, Columbia, Darien Center, Gilford, Minneapolis, Holmdel, Pittsburgh, Camden, Atlanta, Boston, Bethel, Toronto & Hartford Now Available 2
(Date:6/19/2013)... NESS ZIONA, Israel , ... today announced that results from a phase I study ... study in advanced Parkinson,s patients, of ND0612, were presented ... Movement Disorders. ND0612 is a proprietary levodopa/carbidopa liquid drug ... (SC) delivery patch that would maintain constant levodopa plasma ...
(Date:6/19/2013)... 19, 2013   Life Technologies Corporation ... agreement granting Suzhou Ribo Life Sciences (Ribo) the ... in China using Life,s ... siRNA molecules in combination with Invivofectamine® Rx to ... diseases with high unmet medical need in the ...
(Date:6/19/2013)... , 19. Juni 2013 /PRNewswire/ ... dass mit der Entwicklung von SCS ... Schritt in der Beschichtung mit Parylene ... Vorteile von biokompatiblem Parylene mit antimikrobiellen ... Beseitigung schädlicher Mikroorganismen auf beschichteten medizinischen ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
Cached News: